23.74
Usana Health Sciences Inc stock is traded at $23.74, with a volume of 261.41K.
It is up +1.32% in the last 24 hours and down -15.15% over the past month.
Usana Health Sciences Inc is a direct selling and direct-to-consumer nutrition, personal health and wellness company. It developed and manufactured science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness. The company has two reportable segments: direct selling and Hiya direct-to-consumer. The direct selling segment develops and manufactures high quality, science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness in various geographic markets that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children's health and wellness products in the U.S. Key revenue is generated from Direct selling segment.
See More
Previous Close:
$23.43
Open:
$23.26
24h Volume:
261.41K
Relative Volume:
1.30
Market Cap:
$461.88M
Revenue:
$861.97M
Net Income/Loss:
$54.34M
P/E Ratio:
8.3887
EPS:
2.83
Net Cash Flow:
$65.64M
1W Performance:
-4.04%
1M Performance:
-15.15%
6M Performance:
-34.47%
1Y Performance:
-44.80%
Usana Health Sciences Inc Stock (USNA) Company Profile
Name
Usana Health Sciences Inc
Sector
Industry
Phone
(801) 954-7100
Address
3838 WEST PARKWAY BLVD., SALT LAKE CITY, UT
Compare USNA with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
USNA
Usana Health Sciences Inc
|
23.74 | 461.88M | 861.97M | 54.34M | 65.64M | 2.83 |
![]()
KHC
Kraft Heinz Co
|
29.46 | 35.56B | 25.85B | 2.74B | 3.02B | 2.26 |
![]()
GIS
General Mills Inc
|
57.51 | 32.31B | 19.64B | 2.56B | 2.48B | 4.55 |
![]()
K
Kellanova
|
82.37 | 28.46B | 12.75B | 1.34B | 1.13B | 3.87 |
![]()
MKC
Mccormick Co Inc
|
75.32 | 20.81B | 6.68B | 792.60M | 774.40M | 2.94 |
![]()
HRL
Hormel Foods Corp
|
30.58 | 16.80B | 11.92B | 805.04M | 1.01B | 1.46 |
Usana Health Sciences Inc Stock (USNA) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jun-23-23 | Initiated | Sidoti | Buy |
Jul-07-22 | Downgrade | Jefferies | Hold → Underperform |
Apr-14-22 | Initiated | DA Davidson | Neutral |
Dec-17-20 | Initiated | ROTH Capital | Buy |
Aug-22-19 | Initiated | Jefferies | Hold |
Apr-16-19 | Initiated | Tigress Financial | Buy |
Oct-25-18 | Upgrade | Sidoti | Neutral → Buy |
Oct-24-18 | Upgrade | Pivotal Research Group | Hold → Buy |
Apr-23-18 | Downgrade | Pivotal Research Group | Buy → Hold |
Feb-07-18 | Reiterated | Pivotal Research Group | Buy |
Jan-24-18 | Downgrade | Sidoti | Buy → Neutral |
Oct-25-17 | Reiterated | Pivotal Research Group | Buy |
Jul-26-17 | Reiterated | Pivotal Research Group | Buy |
May-03-17 | Upgrade | Pivotal Research Group | Hold → Buy |
May-01-17 | Downgrade | Pivotal Research Group | Buy → Hold |
Feb-08-17 | Reiterated | Pivotal Research Group | Buy |
Jul-28-16 | Reiterated | DA Davidson | Neutral |
Feb-10-16 | Downgrade | DA Davidson | Buy → Neutral |
Oct-16-15 | Upgrade | Sidoti | Neutral → Buy |
Sep-16-15 | Upgrade | DA Davidson | Neutral → Buy |
Aug-06-15 | Downgrade | DA Davidson | Buy → Neutral |
Aug-05-15 | Upgrade | Pivotal Research Group | Hold → Buy |
Jun-26-15 | Initiated | DA Davidson | Buy |
View All
Usana Health Sciences Inc Stock (USNA) Latest News
USANA stock touches 52-week low at $23.63 amid market challenges - Investing.com Nigeria
USANA stock touches 52-week low at $23.63 amid market challenges By Investing.com - Investing.com South Africa
USANA Clinical Study Shows Promise for Improving Skin Appearance - Direct Selling News
USANA Health Sciences Says Skin Treatment Study Shows Significant Improvements in Appearance - marketscreener.com
New Clinical Data: USANA's Anti-Aging Serum Reduces Fine Lines by 15.8% in Just 2 Weeks - Stock Titan
Capital Allocation Trends At USANA Health Sciences (NYSE:USNA) Aren't Ideal - Yahoo Finance
Ionis Pharmaceuticals (IONS) Surges 8.9%: Is This an Indication of Further Gains? - Yahoo Finance
USANA Schedules First Quarter 2025 Earnings Release and Conference Call - MarketScreener
The Market Doesn't Like What It Sees From USANA Health Sciences, Inc.'s (NYSE:USNA) Earnings Yet As Shares Tumble 25% - simplywall.st
USANA stock touches 52-week low at $26.15 amid market challenges - Investing.com Canada
USANA stock touches 52-week low at $26.15 amid market challenges By Investing.com - Investing.com South Africa
USANA Exec. Chairman Kevin Guest Celebrates Guitar Month, Stress Awareness Month for Harmony - MarketScreener
Personal Care Stocks Q4 Teardown: USANA (NYSE:USNA) Vs The Rest - The Globe and Mail
Usana Health Sciences Inc (USNA) Shares Up 3.67% on Mar 26 - GuruFocus
USANA stock touches 52-week low at $26.75 amid market challenges - Investing.com Australia
USANA stock touches 52-week low at $26.75 amid market challenges By Investing.com - Investing.com South Africa
At US$27.31, Is It Time To Put USANA Health Sciences, Inc. (NYSE:USNA) On Your Watch List? - Yahoo Finance
USANA Health Sciences Faces Market Risk with Uncertain Hiya Acquisition Benefits - TipRanks
USANA at Sidoti Small-Cap Conference: Strategic Growth and Hiya Acquisition - Investing.com Canada
USANA names Dr. Kathryn Armstrong as new chief scientific officer - MSN
USANA stock touches 52-week low at $27.58 amid market challenges By Investing.com - Investing.com South Africa
USANA stock touches 52-week low at $27.58 amid market challenges - Investing.com Australia
Usana Health Sciences chief legal officer sells $186,513 in stock By Investing.com - Investing.com Australia
Usana Health Sciences chief legal officer sells $186,513 in stock - Investing.com India
Usana Health Sciences chief commercial officer sells $153,387 in stock - Investing.com
Usana Health Sciences chief commercial officer sells $153,387 in stock By Investing.com - Investing.com UK
Usana Health Sciences director John Turman sells $16,647 in stock By Investing.com - Investing.com Australia
USANA HEALTH SCIENCES INC SEC 10-K Report - TradingView
Usana Health Sciences director John Turman sells $16,647 in stock - Investing.com India
Usana Health Sciences chief sales officer sells $106,669 in stock By Investing.com - Investing.com Australia
Usana Health Sciences chief sales officer sells $106,669 in stock - Investing.com
Usana health sciences director sells common stock for $21,190 - Investing.com India
Usana health sciences director sells common stock for $21,190 By Investing.com - Investing.com South Africa
USANA Health Sciences, Inc. (NYSE:USNA) Shares Bought by Principal Financial Group Inc. - Defense World
USANA Health Sciences, Inc. (NYSE:USNA) Holdings Raised by Rhumbline Advisers - Defense World
Usana Health Sciences reports revenue slide, but says non-MLM acquisition will drive new growth - SupplySide Supplement Journal
Usana Health Sciences CEO sells shares worth $147,350 By Investing.com - Investing.com Australia
Usana Health Sciences CEO sells shares worth $147,350 - Investing.com India
Usana Health Sciences Inc Stock (USNA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Usana Health Sciences Inc Stock (USNA) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Neidig Brent | CHIEF COMMERCIAL OFFICER |
Mar 12 '25 |
Sale |
32.34 |
4,743 |
153,387 |
0 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):